ATE95179T1 - Carbaminsaeureester von substituierten 7-hydroxy2,3,4,5-tetrahydro-1h-3-benzazepinen. - Google Patents

Carbaminsaeureester von substituierten 7-hydroxy2,3,4,5-tetrahydro-1h-3-benzazepinen.

Info

Publication number
ATE95179T1
ATE95179T1 AT89103531T AT89103531T ATE95179T1 AT E95179 T1 ATE95179 T1 AT E95179T1 AT 89103531 T AT89103531 T AT 89103531T AT 89103531 T AT89103531 T AT 89103531T AT E95179 T1 ATE95179 T1 AT E95179T1
Authority
AT
Austria
Prior art keywords
alkyl
halogen
formula
ring
chem
Prior art date
Application number
AT89103531T
Other languages
English (en)
Inventor
Kristian Tage Hansen
Hans Bundgaard
Peter Faarup
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Application granted granted Critical
Publication of ATE95179T1 publication Critical patent/ATE95179T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT89103531T 1988-03-01 1989-02-28 Carbaminsaeureester von substituierten 7-hydroxy2,3,4,5-tetrahydro-1h-3-benzazepinen. ATE95179T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK107688A DK107688D0 (da) 1988-03-01 1988-03-01 Carbaminsyreestere af substituerede 7-hydroxy-2,3,4,5-tetrahydro-1h-3-benzazepiner
EP89103531A EP0331130B1 (de) 1988-03-01 1989-02-28 Carbaminsäureester von substituierten 7-Hydroxy-2,3,4,5-tetrahydro-1H-3-benzazepinen

Publications (1)

Publication Number Publication Date
ATE95179T1 true ATE95179T1 (de) 1993-10-15

Family

ID=8100728

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89103531T ATE95179T1 (de) 1988-03-01 1989-02-28 Carbaminsaeureester von substituierten 7-hydroxy2,3,4,5-tetrahydro-1h-3-benzazepinen.

Country Status (18)

Country Link
US (1) US5017571A (de)
EP (1) EP0331130B1 (de)
JP (1) JPH01254679A (de)
KR (1) KR0126473B1 (de)
AT (1) ATE95179T1 (de)
AU (1) AU613716B2 (de)
CA (1) CA1312863C (de)
DE (1) DE68909448T2 (de)
DK (1) DK107688D0 (de)
ES (1) ES2059592T3 (de)
FI (1) FI94955C (de)
IE (1) IE64247B1 (de)
IL (1) IL89207A0 (de)
NO (1) NO173825C (de)
NZ (1) NZ228151A (de)
PH (1) PH26368A (de)
PT (1) PT89887B (de)
ZA (1) ZA891537B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK67489D0 (da) * 1989-02-14 1989-02-14 Novo Industri As Nye benzazepinderivater
AU666318B2 (en) * 1991-06-28 1996-02-08 Smithkline Beecham Corporation Bicyclic fibrinogen antagonists
US5939412A (en) * 1992-06-26 1999-08-17 Smithkline Beecham Corporation Bicyclic fibrinogen antagonists
US5470850A (en) * 1992-02-24 1995-11-28 Novo Nordisk A/S 2,3,4,5-tetrahydro-1H-3-benzazepines
MA23420A1 (fr) * 1994-01-07 1995-10-01 Smithkline Beecham Corp Antagonistes bicycliques de fibrinogene.
US6458784B1 (en) 1994-06-29 2002-10-01 Smithkline Beecham Corporation Vitronectin receptor antagonists
US5977101A (en) * 1995-06-29 1999-11-02 Smithkline Beecham Corporation Benzimidazoles/Imidazoles Linked to a Fibrinogen Receptor Antagonist Template Having Vitronectin Receptor Antagonist Activity
US20030125317A1 (en) * 1996-10-02 2003-07-03 Smithkline Beecham Corporation Vitronectin receptor antagonists
US7704993B2 (en) 2003-06-17 2010-04-27 Arena Pharmaceuticals, Inc. Benzazepine derivatives and methods of prophylaxis or treatment of 5ht2c receptor associated diseases
US20080009478A1 (en) * 2003-10-22 2008-01-10 Arena Pharmaceuticals, Inc. Benzazepine Derivatives and Methods of Prophylaxis or Treatment of 5Ht2c Receptor Associated Diseases
BRPI0515862A2 (pt) 2004-12-23 2011-10-11 Arena Pharm Inc uso de fentermina e agonista seletivo do receptor de 5ht-2c na preparação de composições, composições moduladoras do receptor de 5ht-2c e forma de dosagem unitária compreendendo as mesmas
US8822727B2 (en) 2008-03-04 2014-09-02 Arena Pharmaceuticals, Inc. Processes for the preparation of intermediates related to the 5-HT2C agonist (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine
KR20130112848A (ko) 2010-06-02 2013-10-14 아레나 파마슈티칼스, 인크. 5-ht2c 수용체 아고니스트의 제조 방법
KR20130138770A (ko) 2010-09-01 2013-12-19 아레나 파마슈티칼스, 인크. 광학적으로 활성 산을 갖는 로르카세린의 염
SG188361A1 (en) 2010-09-01 2013-04-30 Arena Pharm Inc Non-hygroscopic salts of 5-ht2c agonists
US8999970B2 (en) 2010-09-01 2015-04-07 Arena Pharmaceuticals, Inc. Administration of an anti-obesity compound to individuals with renal impairment
EP3485878A1 (de) 2010-09-01 2019-05-22 Arena Pharmaceuticals, Inc. Darreichungsformen von 5-ht2c-agonisten, die nützlich für gewichtskontrolle sind
CA2886875A1 (en) 2012-10-09 2014-04-17 Arena Pharmaceuticals, Inc. Method of weight management

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3393192A (en) * 1965-04-26 1968-07-16 Schering Corp Novel benzazepines
US3609138A (en) * 1967-12-22 1971-09-28 Ciba Geigy Corp 1-aryl-3-benzazepines
US4011319A (en) * 1975-07-02 1977-03-08 Smithkline Corporation Pharmaceutical compositions and methods involving benzazepine derivatives
ZA792044B (en) * 1978-05-08 1980-05-28 Scherico Ltd Substituted 1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepines,process for the preparation thereof,and pharmaceutical compositions containing them
US4284555A (en) * 1979-04-27 1981-08-18 Schering Corporation 7-Chloro-8(substituted amino carbonyloxy)-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines
US4668685A (en) * 1984-07-05 1987-05-26 E.I. Du Pont De Nemours And Company Substituted benzoate ester prodrug derivatives of 3-hydroxymorphinans, which are analgesics or narcotic antagonists
DK180485D0 (da) * 1985-04-22 1985-04-23 Novo Industri As Nitrogenholdige forbindelser
ZA882080B (en) * 1987-03-27 1989-04-26 Schering Corp Substituted benzazepines,their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
CA1312863C (en) 1993-01-19
NZ228151A (en) 1991-08-27
NO173825B (no) 1993-11-01
NO890857D0 (no) 1989-02-28
ZA891537B (en) 1989-11-29
KR0126473B1 (ko) 1997-12-24
NO890857L (no) 1989-09-04
ES2059592T3 (es) 1994-11-16
JPH01254679A (ja) 1989-10-11
NO173825C (no) 1994-02-09
IE890420L (en) 1989-09-01
US5017571A (en) 1991-05-21
DE68909448T2 (de) 1994-02-10
EP0331130B1 (de) 1993-09-29
AU613716B2 (en) 1991-08-08
KR890014494A (ko) 1989-10-24
DE68909448D1 (de) 1993-11-04
AU3090789A (en) 1989-09-07
PH26368A (en) 1992-06-01
FI94955B (fi) 1995-08-15
FI94955C (fi) 1995-11-27
EP0331130A1 (de) 1989-09-06
DK107688D0 (da) 1988-03-01
FI890841A7 (fi) 1989-09-02
FI890841A0 (fi) 1989-02-22
IL89207A0 (en) 1989-09-10
IE64247B1 (en) 1995-07-26
PT89887A (pt) 1989-11-10
PT89887B (pt) 1994-05-31

Similar Documents

Publication Publication Date Title
DE68909448D1 (de) Carbaminsaeureester von substituierten 7-hydroxy-2,3,4,5-tetrahydro-1h-3-benzazepinen.
DE3875748D1 (de) Schimmelbekaempfungsmittel.
DE68920796D1 (de) Chinolinderivate, ihre Herstellung und Verwendung.
TR24332A (tr) Fungisid olarak etkili akrilik asit tuerevleri
FR2372187A1 (de)
NO845147L (no) Fremgangsmaate for fremstilling av forbindelser med anti-psoriasis-aktivitet
DK0436348T3 (da) Pyridylcyklopropanderivater med fungicid aktivitet
ES540332A0 (es) Procedimiento para preparar nuevos pirimido (2,1-b) benzo- tiazoles
ATE28639T1 (de) Derivate von 4-(3-alkynyloxy-2-hydroxy-propyl)piperazin-1-yl-n-phenylacetamid, ihre herstellung und ihre therapeutische verwendung.
SE8804003D0 (sv) Compounds for the treatment of urinary incontinence
FI850325L (fi) Antipsoriatiska naftalener.
DK87689A (da) Carbaminsyreestere af substituerede 7-hydroxy-2,3,4,5-tetrahydro-1h-3-benzazepiner
DE69320730D1 (de) Alkylendiaminderivate
DE3884499D1 (de) Heterozyklische peroxycarbonsaeure.
ATE18205T1 (de) N-sulfenylierte phenethylsulfonamide.
ATE160144T1 (de) Pyridazinon derivate, herstellungsverfahren und verwendung
DK0461343T3 (da) Cyclopropachromenderivater
DE3867202D1 (de) Sulfamoyl-2-benzofurancarbonsaeure-derivate, ihre herstellung und ihre verwendung.
DE69124392D1 (de) Tri(c1-c6 alkoxy)benzolderivat
DE68916126D1 (de) Optisch aktive Piperazin-Derivate.
DE69206447D1 (de) 8-Chloro-benzothiazepin-Verbindung zur Prophylaxe und Behandlung der Folgen der zerebralen Nekrose von Neurozyten.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee